13196-35-5

Basic information

• Product Name: 3-(DIMETHYLAMINO)-1-(2-THIENYL)-1-PROPANONE
• Synonyms: 3-(DIMETHYLAMINO)-1-(2-THIENYL)-1-PROPANONE;3-(DIMETHYLAMINO) 1-(2-THIENYL) PROPANONE;1-(dimethylamino)-3-thiophen-2-ylpropan-2-one
• CAS NO: 13196-35-5
• Molecular Formula: C₉H₁₃NOS
• Molecular Weight: 183.27
• Mol File: 13196-35-5.mol
• Article Data: 14

Chemical Properties

• Melting Point: 178-180 °C
• Boiling Point: 283℃
• Flash Point: 125℃
• Appearance: /
• Density: 1.096
• PKA: 8?+-.0.28(Predicted)
• CAS DataBase Reference: 3-(DIMETHYLAMINO)-1-(2-THIENYL)-1-PROPANONE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(DIMETHYLAMINO)-1-(2-THIENYL)-1-PROPANONE(13196-35-5)
• EPA Substance Registry System: 3-(DIMETHYLAMINO)-1-(2-THIENYL)-1-PROPANONE(13196-35-5)

Safety Data

• Hazardous Substances Data: 13196-35-5(Hazardous Substances Data)

Usage

Uses

3-(Dimethylamino)-1-(2-thienyl)-1-propanone is used in preparation of amine compounds useful in treatment of depression.

Upstream product

• 98-03-3 thiophene-2-carbaldehyde 
• 15787-96-9 1-(thiophen-2-yl)prop-2-yn-1-one 
• 124-40-3 dimethyl amine 
• 19212-35-2 1-(thiophen-2-yl)prop-2-yn-1-ol 
• 88-15-3 2-Acetylthiophene 
• 506-59-2 N,N-dimethylammonium chloride 
• 50-00-0 formaldehyd 
• 5424-47-5 3-(dimethylamino)-1-(thiophen-2-yl)propan-1-one hydrochloride 
• 110-88-3 1,3,5-Trioxan 

Downstream Products

• 78659-38-8 1-(α-thienyl)-3-(2-oxocyclohexyl)propan-1-one 
• 91306-72-8 1-phenyl-4-(thiophen-2-yl)butane-1,4-dione 
• 579489-71-7 3-[4-(2-benzhydryloxy-ethyl)-piperazin-1-yl]-1-thiophen-2-yl-propan-1-one 
• 579489-73-9 3-(4-{2-[bis-(4-fluoro-phenyl)-methoxy]-ethyl}-piperazin-1-yl)-1-thiophen-2-yl-propan-1-one 
• 1425336-85-1 3-(2-phenylmethyl-1H-benzimidazol-1-yl)-1-(thiophen-2-yl)-1-propanone 
• 1047649-09-1 1-(5-(7-diphenylamino-9,9-diethyl-9H-fluoren-2-yl)-thiophen-2-yl)-4-(thiophen-2-yl)-1,4-butanedione 
• 35299-71-9 2,6-bis(thiophen-2-yl)pyridine 
• 144221-02-3 2-phenyl-6-(thiophen-2-yl)pyridine 
• 89814-62-0 2,5-di(thien-2-yl)pyrrole 
• 1081-34-1 2,2':5',2''-terthiophene 
• 91307-07-2 1-(4-Fluoro-phenyl)-2-phenyl-5-thiophen-2-yl-1H-pyrrole 
• 256933-00-3 1-{5-[1-(4-hexyloxy-phenyl)-5-(5-{1-(4-hexyloxy-phenyl)-5-[5-(4-oxo-4-thiophen-2-yl-butyryl)-thiophen-2-yl]-1H-pyrrol-2-yl}-thiophen-2-yl)-1H-pyrrol-2-yl]-thiophen-2-yl}-4-thiophen-2-yl-butane-1,4-dione 
• 256933-05-8 C₄₈H₄₈N₂O₂S₄ 
• 256932-98-6 C₄₆H₄₆N₂O₄S₃ 

Relevant articles and documents

Design of tRNALys3 Ligands: Fragment evolution and linker selection guided by NMR spectroscopy

A fragment-based approach for the synthesis of ligands of tRNA Lys3, the HIV reverse-transcription primer, is described. The use of NMR spectroscopy has proved to be very useful in this approach, not only to detect lowaffinity complexes between small compounds and RNA, but also to provide information on their binding mode and on the way they can be connected. This NMR-spectroscopy-guided analysis enabled us to design micromolar ligands after the optimisation and connection of millimolar fragments with an appropriate linker. The influence of the linker region on the binding affinity and selectivity outlines the importance of having a flexible assemblage strategy with a variety of linkers in such an approach. 2009 Wiley-VCH Verlag GmbH & Co. KGaA.

Metal-free synthesis of β-aminoketones by the reductive hydroamination of ynones

This study describes a cascade method for the synthesis of β-aminoketones through the reductive hydroamination of alkynes under very mild metal-free conditions. It allows for the rapid conversion of ynones and amines into corresponding β-aminoketones with a broad substrate scope and diverse functionalities. This straightforward and easy-to-handle reaction process can be successfully applied for the synthesis of Proroxan and Propipocaine, offering a potential option for the synthesis of drug molecules with the β-aminoketone skeleton.

ARALKYL DIAMINE DERIVATIVES AND USES THEREOF AS ANTIDEPRESSANT

Aralkyl diamine derivative of the following formula, pharmaceutically acceptable salts or uses thereof as antidepressants. The derivatives have triplex inhibiting activities of the reuptake of 5-HT, dopamine and noradrenalin, which can be administered to the patients in need of such treatment in the form of compositions orally or injectedly et al.